Healthcare stakeholders are looking to third parties to help evaluate the value of new medical products. But defining value is complicated. Read about efforts to assess product value, including Avalere’s initiative to develop a value framework that incorporates the patient perspective.
The plans are waiting to see how frameworks will evolve and if physicians embrace them before relying on them to decide which prescription drugs to cover.
On June 1, Josh Seidman participated in a panel discussion hosted by FasterCures to discuss Avalere's collaboration with FasterCures to develop a patient-centric value framework.
FasterCures and Avalere partner to develop a patient-perspective value framework.
With growing out-of-pocket spending for care, patients are increasingly interested in knowing, upfront, how much their care will cost them, and how it relates to the quality and appropriateness of their care. Yet, various barriers often prevent these conversations from occurring during routine clinical encounters.
How can you position your organization for new payment models that emphasize quality of care over quantity of services performed or therapies sold? Engage patients. In this short video, Josh Seidman, Avalere Payment & Delivery Innovation, defines the key imperatives to creating a successful patient engagement strategy that will bring your organization to the forefront of the industry's transition from fee-for-service to value-based care.
Patient engagement has become a new buzz word in drug development. Nevertheless, much uncertainty still exists among stakeholders on how and when to best engage patients in the product development and approval processes.